1
|
Zhang D, Cheng Y, Ji Y, Miao Q, Chen B, Wang J, Wu G, Yuan C, Zheng G, Liu H, Qiu X, Gong J, Ba H, Pan L, Ma X, Qi Y, Shi Y, Zhang Q, Li D, Xu Y. A training program for improving the capacity of infection high-throughput sequencing and diagnosis in China. BMC Med Educ 2024; 24:142. [PMID: 38355463 PMCID: PMC10865699 DOI: 10.1186/s12909-024-05100-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 01/26/2024] [Indexed: 02/16/2024]
Abstract
BACKGROUND Infectious diseases are a serious threat to human especially since the COVID-19 outbreak has proved the importance and urgency of their diagnosis and treatment again. Metagenomic next-generation sequencing (mNGS) has been widely used and recognized in clinical and carried out localized testing in hospitals. Increasing the training of mNGS detection technicians can enhance their professional quality and more effectively realize the application value of the hospital platform. METHODS Based on the initial theoretical understanding and practice of the mNGS platform for localization construction, we have designed a training program to enhance the ability of technicians to detect pathogens by utilizing mNGS, and hence to conduct training practices nationwide. RESULTS Until August 30, 2022, the page views of online classes have reached 51,500 times and 6 of offline small-scale training courses have been conducted. A total of 67 trainees from 67 hospitals have participated in the training with a qualified rate of 100%. After the training course, the localization platform of 1 participating hospital has been put into use, 2 have added the mNGS localization platform for admission, among which 3 have expressed strong intention of localization. CONCLUSIONS This study focuses on the training procedures and practical experience of the project which is the first systematic standardized program of mNGS in the world. It solves the training difficulties in the current industry, and effectively promotes the localization construction and application of mNGS in hospitals. It has great development potential in the future and is worth further promotion.
Collapse
Affiliation(s)
- Dong Zhang
- Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China
- Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing, China
| | - Yunfeng Cheng
- Zhongshan Hospital, Fudan University, 180 Fenglin Rd, 200032, Shanghai, China
| | - Yuan Ji
- Zhongshan Hospital, Fudan University, 180 Fenglin Rd, 200032, Shanghai, China
| | - Qing Miao
- Zhongshan Hospital, Fudan University, 180 Fenglin Rd, 200032, Shanghai, China
| | - Bojiang Chen
- Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, 610041, Chengdu, China
| | - Jing Wang
- Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, 610041, Chengdu, China
| | - Guoqiu Wu
- Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, 210009, Nanjing, Jiangsu, China
| | - Chenyan Yuan
- Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, 210009, Nanjing, Jiangsu, China
| | - Guangjuan Zheng
- Genetic Testing Lab, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Han Liu
- Genetic Testing Lab, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Xinmin Qiu
- Genetic Testing Lab, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Jie Gong
- Department of Clinical Laboratory, Wuhan Center for Clinical Laboratory, Wuhan, Hubei, China
| | - Hongping Ba
- Department of Clinical Laboratory, Wuhan Center for Clinical Laboratory, Wuhan, Hubei, China
| | - Liping Pan
- Department of Clinical Laboratory, Wuhan Center for Clinical Laboratory, Wuhan, Hubei, China
| | - Xiaoling Ma
- Department of Laboratory Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, 230000, Hefei, Anhui, China
| | - Yingjie Qi
- Department of Laboratory Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, 230000, Hefei, Anhui, China
| | - Yuru Shi
- Department of Laboratory Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, 230000, Hefei, Anhui, China
| | - Qi Zhang
- Beijing life oasis public service center, Beijing, China
| | - Dan Li
- BGI Genomics, 518083, Shenzhen, China
| | - Yingchun Xu
- Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Beijing, China.
| |
Collapse
|